Navigation Links
PerOs obtains USDA Establishment and Product Licenses for it's oral vaccine formulations
Date:4/8/2008

MONTREAL, April 8 /PRNewswire/ - The PerOs team is proud to announce the USDA/CVB has granted PerOs an Establishment License for the production of bacterins as well as an autogenous bacterin license utilizing its patented oral delivery formulation methods (Oralject(TM)).

"The approval of our manufacturing facility and our oral vaccine formulation platform in the United States marks a significant milestone for our Company, and we look forward offering these capabilities to the livestock producers and opening new possibilities to the growing aquaculture market, as well as collaborating with traditional animal health companies to expand the oral enablement of the industry as a whole." said Grant Vandenberg, CSO and inventor of Oralject.

PerOs' oral delivery platform focuses on the use of natural products to provide delivery of safe therapeutic and prophylactic compounds. PerOs' formulations are designed to enable the delivery of biological compounds such as vaccines, peptides, and probiotics among others while eliminating the stress associated with handling, injection and other current delivery practices.

This new technology platform will enhance the value of vaccines by offering a labor-minimizing, practical oral delivery approach for the livestock industry and open up new possibilities to the rapidly growing aquaculture market. Oral vaccination will provide animal producers with an innovative tool for disease prevention through vaccination rather than relying on disease treatment using antibiotics.

PerOs' is excited to offer this unique tool to an industry focused on producing safe, healthy food for humans. "Oral delivery will improve the adoption of vaccine usage. Vaccination can now occur when appropriate for disease management rather than based on labor management." said Tom Overbay, Vice President Business Development.

PerOs' first-of-its-kind facility was made possible by the contribution of Benchmark Biolabs development
'/>"/>

SOURCE Peros Systems Technologies Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2

Related biology technology :

1. Intellect Neurosciences, Inc. Obtains Validation of European Patent for Alzheimers Vaccine in 19 Countries
2. Botaneco obtains $2.4 million in funding from AVAC
3. Ganeden Biotech Obtains Self-Affirmed GRAS Status for Probiotic Ingredient, GanedenBC30 (Bacillus coagulans GBI-30, 6086)
4. Neptune Technologies & Bioressources Inc. obtains Complementary Medicine approval in Australia for NKO(R)
5. NEXCORE Technology Obtains Licenses for Revolutionary Fluid Management System
6. China Kangtai Cactus Biotech, Inc. Obtains $500,000 Equity Financing
7. Anesiva Receives FDA Approval for Zingo(TM), a New, Innovative Product to Reduce Pain Associated with Needle Insertion Procedures in Children
8. Angiotech announces additional diameters of sutures to further expand its Quill(TM) SRS PDO product line
9. Barr Confirms Filing an Application With a Paragraph IV Certification for Femcon(R) FE Chewable Oral Contraceptive Product
10. IsoTis Receives FDA Clearance for Accell Family of Products
11. MedImmune Licenses Reverse Genetics Technology to Novartis for Use in Influenza Vaccine Development and Production

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...Nov.24/PRNewswire-FirstCall/--NeurogesX,Inc.(Nasda...pingandcommercializingnovelpainmanagementtherapies...fExecutiveOfficer,isscheduledtopresentatthe21stAnn...er1-2,2009atTheNewYorkPalaceHotelinNewYork,NewYork...alOfficer,willbeavailabletorespondtoquestionsdurin...
(Date:11/24/2009)...ndpointhasbeenmetforpatientswithadvanced-stage,orr...4/PRNewswire-FirstCall/-AEternaZentarisInc.(NASDAQ...ticalcompanyfocusedonendocrinetherapyandoncology,t...ithitstargetedcytotoxicpeptideconjugate,AEZS-108(f...dometrialcancer.Inapersonalizedhealthcareapproach,...
(Date:11/24/2009)...f.,Nov.24/PRNewswire-FirstCall/--GenomicHealth,Inc...icHealth,sExecutiveChairman,willpresentatthe21stAn...nTuesday,December1,2009at10:00a.m.ET. ,, Toacce...tation,visittheInvestorRelationssectionofGenomicHe....Pleaseconnecttothewebsiteatleast15minutespriortot...
(Date:11/24/2009)...RNewswire-FirstCall/--CellTherapeutics,Inc.(CTI)(N...ualPiperJaffrayHealthCareConference.Theconferencew... ,, CTIwillpresentonTuesday,December1at11:00a.m...fCTI,spresentationwillbeavailableat www.celltherap...wards. , ,PiperJaffrayHealthCareConference,NewYor...
Breaking Biology Technology:NeurogesX to Present at Piper Jaffray Health Care Conference 2NeurogesX to Present at Piper Jaffray Health Care Conference 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 2AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 3AEterna Zentaris Announces Positive Results for Phase 2 Study with LHRH-Receptor Targeted Cytotoxic Conjugate AEZS-108 in Endometrial Cancer 4Genomic Health to Present at Piper Jaffray Health Care Conference 2
...c.,(Nasdaq: CYNO ), a leading developer and manuf...treatment systems, today announced the appointment...eting. Lee will develop and,implement worldwide st...s,flagship products, including the Smartlipo MPX, ...hich will debut internationally in the second half...
...oration,(Nasdaq: CRGN ) announced today the compl...ions with holders of the Company,s 4% Convertible,...tes") in which the,Company retired a total of $50....ase price of $43.2 million, reflecting an aggregat...e. CuraGen currently has approximately,$100 millio...
... the electrophysiology of sleep in a wild animal, ...alogram recorders slept 9.63 hours per day6 hours ...onal team of researchers working on the Smithsonia...nd in Panama., We are fascinated that some species... the reasons for variations in sleep patterns, we ...
Other Biology Technology:Cynosure Appoints H. Travis Lee as Vice President of Global Marketing 2Cynosure Appoints H. Travis Lee as Vice President of Global Marketing 3CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million 2CuraGen Repurchases $50.9 Million of 2011 Convertible Debt for $43.2 Million 3First electrophysical recording of sleep in a wild animal 2
(Date:11/25/2009)...s at the California Institute of Technology (Calte...-like behavior in the fruit fly, Drosophila melan...t to the relationship between the neurotransmitter...rder (ADHD), are described in the December issue o... contains only about 20,000 neurons and has long b...
(Date:11/25/2009)... of the Cell Death Research Laboratory in the Univ...awarded the prestigious Johnson & Johnson Focused ... of brain cell damage in Parkinson,s disease. The ... support of innovation and excellence in science, ...rlier this month at an event at the Hyatt Regency ...
(Date:11/25/2009)...t may be just as vital to your health as what you ...iological Studies. Their experiments in mice revea...of genes in the liverthe body,s metabolic clearing...y the body,s circadian clock as conventional wisdo...ivity of a large number of genes completely indepe...
Breaking Biology News(10 mins):Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 2Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 3Caltech scientists find emotion-like behaviors, regulated by dopamine, in fruit flies 4Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2Feeding the clock 2Feeding the clock 3Reported Use of AMAGs Feraheme 28ferumoxytol 29 Continues To Be Low But a Number of Nephrologists Are On the Verge of Use 6464 1Reported Use of AMAGs Feraheme 28ferumoxytol 29 Continues To Be Low But a Number of Nephrologists Are On the Verge of Use 6464 2Proteon Initiates Second Phase 1 2 Clinical Study of PRT 201 in Hemodialysis Patients 6461 1Proteon Initiates Second Phase 1 2 Clinical Study of PRT 201 in Hemodialysis Patients 6461 2Amid the flu epidemic dont forget RSV in young children 61928 1Amid the flu epidemic dont forget RSV in young children 61928 2Amid the flu epidemic dont forget RSV in young children 61928 3
...cules and regulatory pathways in human glomerular ... the Medizinische Poliklinik, Munich, the Universi...Cancer Research Center, sanofi-aventis, and Genoma... Proceedings of the National Academy of Sciences o... show how new bioinformatics approaches allow rapi...
...versities in Italy and Virginia Tech in the United... that is responsible for the production xanthureni...ying mosquitoes. XA plays a key role in the sexual...falciparum) in A. gambiae mosquitoes. Interfering ...velopment of drugs and insecticides to block malar...
...is always gratifying for the avid angler, one caug...sland in December proved even more satisfying for ...nefish and Tarpon Unlimited (BTU) and the Universi...heric Science. The fish was a record catch, repres...ured at more than double the previous distance rec...
Other Biology News:Oxidation defense in mosquitoes benefits malaria parasite 2Record bonefish 2
Anti-Human L-Ficolin Monoclonal Antibody, Unconjugated, Clone GN4 from Cell Sciences
Anti-Jak3 Antibody, Unconjugated from Cell Signaling Technology
Mouse Anti-Human B3GALT2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Mouse Anti-Human WASF2 Polyclonal Antibody, Unconjugated from ABR-Affinity BioReagents
Biology Products: